Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.

Petzold A, Woodhall M, Khaleeli Z, Tobin WO, Pittock SJ, Weinshenker BG, Vincent A, Waters P, Plant GT.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1021-1026. doi: 10.1136/jnnp-2019-320493. Epub 2019 May 22.

PMID:
31118222
2.

Clinical relevance of cortical network dynamics in early primary progressive MS.

Tur C, Kanber B, Eshaghi A, Altmann DR, Khaleeli Z, Prados F, Ourselin S, Thompson AJ, Gandini Wheeler-Kingshott CA, Toosy AT, Ciccarelli O.

Mult Scler. 2019 Feb 25:1352458519831400. doi: 10.1177/1352458519831400. [Epub ahead of print]

3.

Remember the retina: retinal disorders presenting to neurologists.

Khaleeli Z, Tucker WR, Del Porto L, Virgo JD, Plant GT.

Pract Neurol. 2018 Apr;18(2):84-96. doi: 10.1136/practneurol-2016-001534. Epub 2018 Mar 23. Review.

PMID:
29572353
4.

A novel HTRA1 exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient.

Khaleeli Z, Jaunmuktane Z, Beaufort N, Houlden H, Haffner C, Brandner S, Dichgans M, Werring D.

J Neurol. 2015 May;262(5):1369-72. doi: 10.1007/s00415-015-7769-5. Epub 2015 May 10. No abstract available.

PMID:
25957642
5.

HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.

Tur C, Ramagopalan S, Altmann DR, Bodini B, Cercignani M, Khaleeli Z, Miller DH, Thompson AJ, Ciccarelli O.

Neurology. 2014 Nov 4;83(19):1712-8. doi: 10.1212/WNL.0000000000000959. Epub 2014 Oct 8.

6.

Brain atrophy and lesion load predict long term disability in multiple sclerosis.

Popescu V, Agosta F, Hulst HE, Sluimer IC, Knol DL, Sormani MP, Enzinger C, Ropele S, Alonso J, Sastre-Garriga J, Rovira A, Montalban X, Bodini B, Ciccarelli O, Khaleeli Z, Chard DT, Matthews L, Palace J, Giorgio A, De Stefano N, Eisele P, Gass A, Polman CH, Uitdehaag BM, Messina MJ, Comi G, Filippi M, Barkhof F, Vrenken H; MAGNIMS Study Group.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1082-91. doi: 10.1136/jnnp-2012-304094. Epub 2013 Mar 23.

PMID:
23524331
7.

Corpus callosum damage predicts disability progression and cognitive dysfunction in primary-progressive MS after five years.

Bodini B, Cercignani M, Khaleeli Z, Miller DH, Ron M, Penny S, Thompson AJ, Ciccarelli O.

Hum Brain Mapp. 2013 May;34(5):1163-72. doi: 10.1002/hbm.21499. Epub 2012 Feb 13.

PMID:
22328451
8.

Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.

Tur C, Penny S, Khaleeli Z, Altmann DR, Cipolotti L, Ron M, Thompson AJ, Ciccarelli O.

Mult Scler. 2011 Nov;17(11):1324-32. doi: 10.1177/1352458511410341. Epub 2011 Jul 29.

PMID:
21803874
9.

Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS.

Tur C, Khaleeli Z, Ciccarelli O, Altmann DR, Cercignani M, Miller DH, Thompson AJ.

J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):423-8. doi: 10.1136/jnnp.2010.209890. Epub 2010 Oct 25.

PMID:
20974648
10.

[Copper deficiency as a treatable cause of poor balance].

Khaleeli Z, Healy DG, Briddon A, Lunn MP, Reilly MM, Land J, Giovannoni G.

Praxis (Bern 1994). 2010 Sep 22;99(19):1153-6. doi: 10.1024/1661-8157/a000258. German. No abstract available.

PMID:
20859879
11.

Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study.

Anderson VM, Fisniku LK, Khaleeli Z, Summers MM, Penny SA, Altmann DR, Thompson AJ, Ron MA, Miller DH.

Mult Scler. 2010 Sep;16(9):1083-90. doi: 10.1177/1352458510374893. Epub 2010 Jul 14.

PMID:
20630904
12.

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

Bodini B, Battaglini M, De Stefano N, Khaleeli Z, Barkhof F, Chard D, Filippi M, Montalban X, Polman C, Rovaris M, Rovira A, Samson R, Miller D, Thompson A, Ciccarelli O.

J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):72-7. doi: 10.1136/jnnp.2009.201574. Epub 2010 Jul 13.

13.

Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

Bosma LV, Kragt JJ, Brieva L, Khaleeli Z, Montalban X, Polman CH, Thompson AJ, Tintoré M, Uitdehaag BM.

Mult Scler. 2010 Jul;16(7):862-7. doi: 10.1177/1352458510370464. Epub 2010 May 20.

PMID:
20488826
14.

Copper deficiency as a treatable cause of poor balance.

Khaleeli Z, Healy DG, Briddon A, Lunn MP, Reilly MM, Land J, Giovannoni G.

BMJ. 2010 Apr 12;340:c508. doi: 10.1136/bmj.c508. No abstract available.

PMID:
20385722
15.

Lesion enhancement diminishes with time in primary progressive multiple sclerosis.

Khaleeli Z, Ciccarelli O, Mizskiel K, Altmann D, Miller DH, Thompson AJ.

Mult Scler. 2010 Mar;16(3):317-24. doi: 10.1177/1352458509358090.

PMID:
20203148
16.

Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.

Penny S, Khaleeli Z, Cipolotti L, Thompson A, Ron M.

Neurology. 2010 Feb 16;74(7):545-52. doi: 10.1212/WNL.0b013e3181cff6a6.

PMID:
20157157
17.

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.

Montalban X, Sastre-Garriga J, Filippi M, Khaleeli Z, Téllez N, Vellinga MM, Tur C, Brochet B, Barkhof F, Rovaris M, Miller DH, Polman CH, Rovira A, Thompson AJ.

Mult Scler. 2009 Dec;15(12):1459-65. doi: 10.1177/1352458509348422. Epub 2009 Dec 7.

PMID:
19995843
18.

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G.

Neurology. 2009 Jul 7;73(1):32-8. doi: 10.1212/WNL.0b013e3181aa29fe. Epub 2009 May 20.

19.

The search for responsive clinical endpoints in primary progressive multiple sclerosis.

Bosma LV, Kragt JJ, Brieva L, Khaleeli Z, Montalban X, Polman CH, Thompson AJ, Tintoré M, Uitdehaag BM.

Mult Scler. 2009 Jun;15(6):715-20. doi: 10.1177/1352458509102626. Epub 2009 Apr 21.

PMID:
19383646
20.

Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.

Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O.

Hum Brain Mapp. 2009 Sep;30(9):2852-61. doi: 10.1002/hbm.20713.

PMID:
19172648
21.

Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis.

Khaleeli Z, Altmann DR, Cercignani M, Ciccarelli O, Miller DH, Thompson AJ.

Arch Neurol. 2008 Nov;65(11):1454-9. doi: 10.1001/archneur.65.11.1454.

PMID:
19001163
22.

Harmony or hegemony? The rise and fall of the native medical institution, Calcutta, 1822-35.

Khaleeli Z.

South Asia Res. 2001;21(1):77-104. No abstract available.

PMID:
18652048
23.

Diagnosis and management of primary progressive multiple sclerosis.

Jenkins TM, Khaleeli Z, Thompson AJ.

Minerva Med. 2008 Apr;99(2):141-55.

PMID:
18431323
24.

Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study.

Khaleeli Z, Ciccarelli O, Manfredonia F, Barkhof F, Brochet B, Cercignani M, Dousset V, Filippi M, Montalban X, Polman C, Rovaris M, Rovira A, Sastre-Garriga J, Vellinga M, Miller D, Thompson A.

Ann Neurol. 2008 Jun;63(6):790-3. doi: 10.1002/ana.21375.

PMID:
18383506
25.

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.

Rovaris M, Judica E, Sastre-Garriga J, Rovira A, Sormani MP, Benedetti B, Korteweg T, De Stefano N, Khaleeli Z, Montalban X, Barkhof F, Miller DH, Polman C, Thompson AJ, Filippi M.

Mult Scler. 2008 May;14(4):455-64. doi: 10.1177/1352458507085129. Epub 2008 Jan 21.

PMID:
18208869
26.

Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability.

Khaleeli Z, Cercignani M, Audoin B, Ciccarelli O, Miller DH, Thompson AJ.

Neuroimage. 2007 Aug 1;37(1):253-61. Epub 2007 May 18.

PMID:
17566765
27.

Normal-appearing brain t1 relaxation time predicts disability in early primary progressive multiple sclerosis.

Manfredonia F, Ciccarelli O, Khaleeli Z, Tozer DJ, Sastre-Garriga J, Miller DH, Thompson AJ.

Arch Neurol. 2007 Mar;64(3):411-5.

PMID:
17353385
28.

Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.

Khaleeli Z, Sastre-Garriga J, Ciccarelli O, Miller DH, Thompson AJ.

J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1076-82. Epub 2007 Feb 7.

Supplemental Content

Loading ...
Support Center